Intravenous solutions for a derivative of staurosporine

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/55 (2006.01) A61K 9/107 (2006.01) A61K 9/127 (2006.01) A61K 31/553 (2006.01) A61K 47/00 (2006.01)

Patent

CA 2162342

The invention relates to a novel advantageous dosage form for sparingly soluble stauro- sporin derivatives, especially N-benzoyl-staurosporin. The dosage form is administrable intravenously in the form of a nanoemulsion and comprises as solubilisers a combination of phospholipids, triglycerides and partial fatty acid esters of polyoxyethylene sorbitan.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intravenous solutions for a derivative of staurosporine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intravenous solutions for a derivative of staurosporine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous solutions for a derivative of staurosporine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1569706

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.